{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:12:22Z","timestamp":1785510742842,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2208085MH248"],"award-info":[{"award-number":["2208085MH248"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.prp.2026.156470","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:00:40Z","timestamp":1776142840000},"page":"156470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["U2SURP increases CREB3L2 RNA stability and RIOK1 transcription to enhance lenvatinib resistance in hepatocellular carcinoma cells"],"prefix":"10.1016","volume":"282","author":[{"given":"Tiantian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156470_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2026.156470_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2026.156470_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2026.156470_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156470_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188391","article-title":"Lenvatinib for hepatocellular carcinoma: from preclinical mechanisms to anti-cancer therapy","volume":"1874","author":"Zhao","year":"2020","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156470_bib6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2147\/JHC.S411806","article-title":"Application and resistance mechanisms of lenvatinib in patients with advanced hepatocellular carcinoma","volume":"10","author":"Tao","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.prp.2026.156470_bib7","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/liv.15953","article-title":"Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy","volume":"44","author":"Qin","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.prp.2026.156470_bib8","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1038\/s41467-021-25195-1","article-title":"Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma","volume":"12","author":"Scagliola","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2026.156470_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12967-021-02877-4","article-title":"eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway","volume":"19","author":"Sun","year":"2021","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.prp.2026.156470_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115335","article-title":"Regulatory mechanisms of the cAMP-responsive element binding protein 3 (CREB3) family in cancers","volume":"166","author":"Yuxiong","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2026.156470_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.650338","article-title":"CREB3L2 modulates nerve growth factor-induced cell differentiation","volume":"14","author":"Sampieri","year":"2021","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.prp.2026.156470_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12943-022-01658-x","article-title":"CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment","volume":"21","author":"Pan","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156470_bib13","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1038\/s41388-021-02026-7","article-title":"Single-cell analysis reveals androgen receptor regulates the ER-to-Golgi trafficking pathway with CREB3L2 to drive prostate cancer progression","volume":"40","author":"Hu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2026.156470_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41420-023-01704-7","article-title":"The RioK1 network determines p53 activity at multiple levels","volume":"9","author":"Damizia","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2026.156470_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189100","article-title":"A role for RIO kinases in the crosshair of cancer research and therapy","volume":"1879","author":"Ghandadi","year":"2024","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156470_bib16","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1038\/s41388-022-02352-4","article-title":"RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2","volume":"41","author":"Chen","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2026.156470_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.120094","article-title":"Activation of YBX1 and JAK2\/STAT3 pathways by RIOK1 increases lenvatinib resistance in hepatocellular carcinoma cells","volume":"1873","author":"Cao","year":"2026","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"key":"10.1016\/j.prp.2026.156470_bib18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/15476286.2020.1822636","article-title":"Identification of spliceosome components pivotal to breast cancer survival","volume":"18","author":"An","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.prp.2026.156470_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216124","article-title":"MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression","volume":"560","author":"Deng","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2026.156470_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13062-024-00459-0","article-title":"RARRES1 inhibits hepatocellular carcinoma progression and increases its sensitivity to lenvatinib through interaction with SPINK2","volume":"19","author":"Guo","year":"2024","journal-title":"Biol. Direct"},{"key":"10.1016\/j.prp.2026.156470_bib21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3724\/abbs.2023122","article-title":"SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR\/IL-1beta pathway","volume":"55","author":"Fan","year":"2023","journal-title":"Acta Biochim Biophys. Sin."},{"key":"10.1016\/j.prp.2026.156470_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11010046","article-title":"GOLT1B activation in Hepatitis C Virus-infected hepatocytes links ER trafficking and viral replication","volume":"11","author":"Butterworth","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.prp.2026.156470_bib23","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mc.23775","article-title":"AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K\/AKT\/mTOR pathway","volume":"63","author":"Zhu","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.prp.2026.156470_bib24","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.2147\/CMAR.S204864","article-title":"Identification of a novel DNA repair-related prognostic signature predicting survival of patients with hepatocellular carcinoma","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.prp.2026.156470_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000539349","article-title":"Hepatocellular carcinoma: prevention, diagnosis, and treatment","volume":"33","author":"Feng","year":"2024","journal-title":"Med Princ. Pr."},{"key":"10.1016\/j.prp.2026.156470_bib26","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1038\/s41467-019-11894-3","article-title":"Pituitary cell translation and secretory capacities are enhanced cell autonomously by the transcription factor Creb3l2","volume":"10","author":"Khetchoumian","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2026.156470_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6848","article-title":"Potentially functional genetic variants in ferroptosis-related CREB3 and GALNT14 genes predict survival of hepatitis B virus-related hepatocellular carcinoma","volume":"13","author":"Zhan","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.prp.2026.156470_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/JHC.S398713","article-title":"Exploring prognosis, tumor microenvironment and tumor immune infiltration in hepatocellular carcinoma based on ATF\/CREB transcription factor family gene-related model","volume":"10","author":"Shen","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.prp.2026.156470_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125982","article-title":"Promotion of cancer cell proliferation by cleaved and secreted luminal domains of ER stress transducer BBF2H7","volume":"10","author":"Iwamoto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2026.156470_bib30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41419-025-08250-3","article-title":"Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma","volume":"16","author":"Yang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2026.156470_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41586-020-2929-x","article-title":"Structural basis for the final steps of human 40S ribosome maturation","volume":"587","author":"Ameismeier","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.prp.2026.156470_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70597","article-title":"RIOK1: a novel oncogenic driver in hepatocellular carcinoma","volume":"14","author":"Ruan","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.prp.2026.156470_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaf058","article-title":"Ribosome biogenesis is increased in hepatocellular carcinoma and represents a potential therapeutic target","volume":"8","author":"Geisler","year":"2026","journal-title":"NAR Cancer"},{"key":"10.1016\/j.prp.2026.156470_bib34","first-page":"1067","article-title":"Elevated expression of RIOK1 is correlated with breast cancer hormone receptor status and promotes cancer progression","volume":"52","author":"Huang","year":"2020","journal-title":"Cancer Res Treat."},{"key":"10.1016\/j.prp.2026.156470_bib35","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.ajpath.2023.05.013","article-title":"The oncogenic protein kinase\/ATPase RIOK1 is up-regulated via the c-myc\/E2F transcription factor axis in prostate cancer","volume":"193","author":"Handle","year":"2023","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2026.156470_bib36","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/ijc.32331","article-title":"U2-related proteins CHERP and SR140 contribute to colorectal tumorigenesis via alternative splicing regulation","volume":"145","author":"Wang","year":"2019","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.prp.2026.156470_bib37","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1261\/rna.078935.121","article-title":"Alternative splicing regulation of cell-cycle genes by SPF45\/SR140\/CHERP complex controls cell proliferation","volume":"27","author":"Martin","year":"2021","journal-title":"RNA"},{"key":"10.1016\/j.prp.2026.156470_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-024-01647-1","article-title":"Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:40:04Z","timestamp":1785508804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S0344033826001238"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156470","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"U2SURP increases CREB3L2 RNA stability and RIOK1 transcription to enhance lenvatinib resistance in hepatocellular carcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156470"}}